Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Magnetic imaging agent
Reexamination Certificate
2006-04-18
2006-04-18
Hartley, Michael G. (Department: 1616)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Magnetic imaging agent
C424S009361, C424S009363, C424S009364
Reexamination Certificate
active
07029655
ABSTRACT:
The invention relates to a novel class of magnetic resonance imaging agents that can cross the blood brain barrier and provide accurate magnetic resonance imaging of the brain, especially magnetic resonance images of amyloid deposits associated with Alzheimer's disease.
REFERENCES:
patent: 4637988 (1987-01-01), Hinshaw et al.
patent: 4647447 (1987-03-01), Gries et al.
patent: 4678667 (1987-07-01), Meares et al.
patent: 4822594 (1989-04-01), Gibby
patent: 4837169 (1989-06-01), Toner
patent: 4877872 (1989-10-01), Morgan et al.
patent: 4885363 (1989-12-01), Tweedle et al.
patent: 5087440 (1992-02-01), Cacheris et al.
patent: 5095099 (1992-03-01), Parkinson et al.
patent: 5133956 (1992-07-01), Garlich et al.
patent: 5155215 (1992-10-01), Ranney
patent: 5188816 (1993-02-01), Sherry et al.
patent: 5219553 (1993-06-01), Kraft et al.
patent: 5230883 (1993-07-01), Kornguth et al.
patent: 5256395 (1993-10-01), Barbet et al.
patent: 5262532 (1993-11-01), Tweedle et al.
patent: 5292414 (1994-03-01), Sessler et al.
patent: 5310539 (1994-05-01), Williams
patent: 5322681 (1994-06-01), Klaveness
patent: 5332567 (1994-07-01), Goldenberg
patent: 5338532 (1994-08-01), Tomalia et al.
patent: 5358704 (1994-10-01), Desreux et al.
patent: 5407657 (1995-04-01), Unger et al.
patent: 5419893 (1995-05-01), Berg et al.
patent: 5446145 (1995-08-01), Love et al.
patent: 5466438 (1995-11-01), Unger et al.
patent: 5466439 (1995-11-01), Gibby et al.
patent: 5531978 (1996-07-01), Berg et al.
patent: 5554748 (1996-09-01), Sieving et al.
patent: 5622821 (1997-04-01), Selvin et al.
patent: 5707605 (1998-01-01), Meade et al.
patent: 5900228 (1999-05-01), Meade et al.
patent: 5914095 (1999-06-01), Watson
patent: 5955605 (1999-09-01), Axworthy et al.
patent: 5980862 (1999-11-01), Meade et al.
patent: 6054114 (2000-04-01), Lansbury, Jr. et al.
patent: 2197074 (1994-08-01), None
patent: 2139374 (1995-07-01), None
patent: 2182686 (1995-08-01), None
patent: WO 90/12050 (1990-10-01), None
patent: WO 92/19264 (1992-11-01), None
patent: WO 95/27705 (1995-10-01), None
patent: WO 95/28966 (1995-11-01), None
patent: WO 95/31444 (1995-11-01), None
patent: WO 95/32741 (1995-12-01), None
patent: WO 96/23526 (1996-08-01), None
patent: WO 96/38184 (1996-12-01), None
patent: WO 97/21431 (1997-06-01), None
patent: WO 97/32862 (1997-09-01), None
patent: WO 97/36619 (1997-10-01), None
patent: WO 99/21592 (1999-05-01), None
Aguayo, J.B., et al. “Nuclear Magnetic Resonance Imaging of a Single Cell,” Nature, Letters to Nature 322:190-191 (Jul. 10, 1986).
Alexander, “Design and Synthesis of Macrocyclic Ligands and Their Complexes of Lanthanides and Antinides,” Chem. Review, 95:273-342 (1995).
Borch, R.F., et al. “The Cyanohydridoborate Anion as a Selective Reducing Agent,” Journal of the American Chemical Society 93(12):2897-2904 (Jun. 16, 1971).
Cho, Z.H., et al. “Some Experiences on a 4μμm NMR Microscopy,” Book of Abstracts, vol. 1, p. 233, Society of Magnetic Resonance in Medicine, 6th Annual Meeting and Exhibition, Aug. 17-21, 1987, New York City, NY.
Grynkiewicz, G., et al. “A New Generation of Ca2+ Indicators with Greatly Improved Fluorescence Properties,” The Journal of Biological Chemistry, 260(6):3440-3450 (1985).
Hennessy, M.J., et al. “NMR Surface Coil Microscopy,” Book of Abstracts, vol. 2, p. 461-462, Society of Magnetic Resonance in Medicine, 5th Annual Meeting and Exhibition, Aug. 19-22, 1986, Montreal, Quebec, Canada.
Hoult, D.I., et al. “The Signal-to-Noise Ratio of the Nuclear Magnetic Resonance Experiment,” Journal of Magnetic Resonance, 24: 71-85 (1976).
Jackels, “Section III: Enhancement Agents for Magnetic Resonance and Ultrasound Imaging. Chapter 20: Enhancement Agents for Magnetic Resonance Imaging: Fundamentals,” Pharm. Med. Imag. Section III, Chap. 20, pp. 645-661 (1990).
Jacobs and Fraser, “Magnetic Resonance Microscopy of Embryonic Cell Lineages and Movements,”Science, 263:681-684 (1994).
Johnson, G.A., et al., “MR Microscopy at 7.0 T,” Works in Progress, Society of Magnetic Resonance in Medicine, Sixth Annual Meeting and Exhibition, Aug. 17-21, 1987, New York City, NY. p. 23.
Li, et al., “A Calcium-Sensitive Magnetic Resonance Imaging Contrast Agent,” J. Am. Chem. Soc., 121:1413-1414 (1999).
Meade, T.J. et al., “Hydrophobic, Regiospecific Guest Binding by Transition-Metal Host Complexes Having Permanent Voids as Revealed by FT-NMR Relaxation Studies,” J. Am. Chem. Soc., 108:1954-1962 (1986).
Meyer et al., “Advances in Macrocyclic Gadolinium Complexes as Magnetic Resonance Imaging Contrast Agents,” Investigative Radiology, 25(1):S53-S55 (Sep. 1990).
Moats, et al., “A “Smart” Magnetic Resonance Imaging Agent That Reports on Specific Enzymatic Activity,” Angew. Chem. Int. Ed. Engl., 36(7):726-728 (Apr. 1997).
Moi, M.K., et al. “The Peptide Way to Macrocyclic Bifunctional Chelating Agents: Synthesis of 2- (p-Nitrobenzyl) -1,4,7,10-tetraazacyclododecan- N, N, N, N-tetraacetic Acid and Study of Its Yttrium (III) Complex,” J. Am. Chem. Soc. 110(18):6266-6267 (1988).
Nijhof, E.J., et al. “High-Resolution Proton Imaging at 4.7 Tesla,” Proceedings of Soc. Magn. Reson. Med., p. 925 (1987).
Runge, V.M., et al. “Future Directions in Magnetic Resonance Contrast Media,” Top Magn. Reson. Imaging., 3(2):85-97 (1991).
Russell, E.J., et al. “Multicenter Double-Blind Placebo-Controlled Study of Gadopentetate Dimeglumine as an MR Contrast Agent: Evaluation in Patients with Cerebral Lesions,” American Journal of Roentgenology, 152:813-823 (Apr. 1989).
Shukla, et al., “Design of Conformationally Rigid Dimeric MRI Agents,” Magnetic Resoance in Medicine, 36(6): 928-931 (1996).
Sillerud, L.O., et al. “Proton NMR Microscopy of Intact Multicellular Tumor Spheroids,” Book of Abstracts, vol. 1, p. 468, Society of Magnetic Resonance in Medicine, 6th Annual Meeting and Exhibition, Aug. 17-21, 1987, New York City, NY.
Staubli and Meade, “The Design and Synthesis of Fluorescently Detectable Magnetic Resonance imaging Agents for Embryonic Cell Lineage Analysis,”American Chemical Society: Division of Inorganic Chemistry, 209th ACS National Meeting, Anaheim, California. Abstract No. 385 (Apr. 2-6, 1995).
Tsien, R.Y. “New Calcium Indicators and Buffers with High Selectivity Against Magnesium and Protons: Design, Synthesis, and Properties of Prototype Structures,” Biochemistry, 19(11):2396-2404 (1980).
Tweedle, M.F., et al. “Considerations Involving Paramagnetic Coordination Compounds as Useful NMR Contrast Agents,” Nucl. Med. Bio. 15(1):31-36 (1988).
Allen Matthew J.
Fraser Scott
Jacobs Russell E.
Meade Thomas J.
California Institute of Technology
Dorsey & Whitney LLP
Hartley Michael G.
Kosslak, Esq. Renee M.
Silva, Esq. Robin M.
LandOfFree
Magnetic resonance imaging agents for in vivo labeling and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Magnetic resonance imaging agents for in vivo labeling and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Magnetic resonance imaging agents for in vivo labeling and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3597598